JUNE, 20249Two Product Lines Kerecis has two product lines. Kerecis Omega3 fish-skin products are designed for use on wounds and burns. Clinical studies have found that these products heal wounds quicker than competitive products, provide an infection barrier, and reduce pain. Additionally, the products are non-allergenic and there are no cultural barriers to use. "Kerecis is the only company in the world supplying fish skin for these types of medical procedures," adds Fertram.The second product line, Kerecis Omega3 Viruxal, contains patented fatty acids, which help control infections. This system is used in Kerecis Primary Wound Spray, which has been on the market for years in multiple countries. The Viruxal technology has also shown promise as a treatment for early-stage COVID-19 when administrated to the oral and nasal cavities.Transforming the FutureThe Kerecis products have dramatically impacted people's lives, including the life of Dennis Reneau, a former U.S. Marine and top U.S. body builder who developed two deep chronic wounds on his feet. For more than two years he was in such serious pain that he had trouble sleeping and could not walk, even on crutches. His wounds were so bad that his doctors recommended a double amputation. He had given up hope when he met Dr. Mark D. Suski, who treated him with Kerecis Omega3 Wound. Within two days, the pain had decreased dramatically. The wounds started to shrink within three weeks and were completely healed in a few months.Dennis, who has since resumed his normal life, is just one example of how Kerecis is transforming lives. In the future the company will add to the scientific evidence of its technology, which has already been well-established in multiple clinical studies including some large, randomized, controlled studies. The company now has three clinical trials underway. One is evaluating the effectiveness of the Kerecis Omega3 Viruxal system on early-stage COVID-19 patients, and two others focus on diabetic wounds. "Recently the Institut Curie in Paris used the fish-skin products to treat wounds after surgery for neck cancer. They found that patients had less pain and fewer infections with the fish skin than with the standard of care," adds Fertram, who plans to submit several other products to the FDA for approval.Overall, Fertram remains motivated by the same desire to help people by using natural resources that inspired the company in the first place. He continues to look for strategic ways to solve problems that matter. And Fertram inspires the Kerecis team to do their best because he's created a community focused on making a difference. Fertram Sigurjonsson, the CEO, President and Chairman of Kerecis
< Page 8 | Page 10 >